{"items": "15", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Illumina announces preliminary results of annual meeting", "url": "https://www.prnewswire.com/news-releases/illumina-announces-preliminary-results-of-annual-meeting-301835034.html", "time_published": "20230525T181700", "authors": ["Inc.", "Illumina"], "summary": "Illumina shareholders re-elect eight of nine Illumina directors", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.259176, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.070725", "ticker_sentiment_score": "0.098492", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.62523", "ticker_sentiment_score": "0.352192", "ticker_sentiment_label": "Bullish"}]}, {"title": "Icahn wins one board seat at Illumina", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/icahn-wins-one-board-seat-illumina-2023-05-25/", "time_published": "20230525T175900", "authors": ["Reuters"], "summary": "Icahn wins one board seat at ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/2NJNCPNURVNEJDGYDRK7KT5M4M.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.026044, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.699089", "ticker_sentiment_score": "0.053278", "ticker_sentiment_label": "Neutral"}]}, {"title": "Icahn Nominee Elected to Illumina's Board", "url": "https://www.wsj.com/articles/icahn-nominee-elected-to-illuminas-board-6bcee863", "time_published": "20230525T174500", "authors": ["Peter Loftus"], "summary": "Shareholders selected one of the activist investor's picks, who will replace on the board a director who had served as Illumina's chairman.", "banner_image": "https://images.wsj.net/im-788928?width=700&height=468", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.02498, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.716023", "ticker_sentiment_score": "-0.039747", "ticker_sentiment_label": "Neutral"}]}, {"title": "Check Out What Whales Are Doing With ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/05/32581126/check-out-what-whales-are-doing-with-ilmn", "time_published": "20230525T173316", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bullish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.186738, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.813694", "ticker_sentiment_score": "0.316097", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina shareholders vote to install Carl Icahn board nominee, oust chair", "url": "https://www.cnbc.com/2023/05/25/illumina-installs-carl-icahn-board-nominee-ousts-chair-.html", "time_published": "20230525T172144", "authors": ["Annika Kim Constantino"], "summary": "Carl Icahn has accused Illumina's management and board of poor oversight, particularly with regard to the company's acquisition of cancer test maker Grail.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107164604-1670850801645-gettyimages-1240065665-RIVIAN_AUTOMOTIVE.jpeg?v=1684944598", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.091192, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.630923", "ticker_sentiment_score": "0.210501", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina shareholders vote chairman out", "url": "https://www.axios.com/2023/05/25/illumina-shareholders-vote-chairman-thompson-out", "time_published": "20230525T163311", "authors": ["https://www.axios.com/authors/mflaherty", "Michael Flaherty"], "summary": "Illumina investors voted chairman John Thompson off the board of directors on Thursday as Carl Icahn's months-long battle against the $32 billion gene-sequencing equipment maker crossed the finish line at the company's annual meeting.", "banner_image": "https://images.axios.com/bsIzFRtIkL2VnoXwVVsgu3j6BKE=/0x0:1920x1080/1920x1080/2023/05/24/1684966022567.jpg?w=1920", "source": "Axios", "category_within_source": "Markets", "source_domain": "www.axios.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.111969, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.091509", "ticker_sentiment_score": "0.034522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.509589", "ticker_sentiment_score": "0.162863", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Top Stories Thursday, May 25: Bill Ackman Thinks Rival Icahn's Firm Still Overvalued, Nvidia Nears $1 Trillion Market Cap, Freshpet's Largest Shareholder Pushes For Board Overhaul - NVIDIA  ( NASDAQ:NVDA ) ", "url": "https://www.benzinga.com/news/earnings/23/05/32573579/bill-ackman-thinks-rival-icahns-firm-still-overvalued-nvidia-nears-1-trillion-market-cap-freshpets-", "time_published": "20230525T132650", "authors": ["Vandana Singh"], "summary": "Pershing Square Capital Management founder and CEO Bill Ackman weighed in on billionaire Carl Icahn and his company following the release of a short report by Hindenburg Research. Ackman commented that there were some interesting takeaways from the unfolding situation.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/carl_icahn_-_photo_by_insider_monkey_via_flickr_creative_commons_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.94762"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.161315, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.114318", "ticker_sentiment_score": "0.124476", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.114318", "ticker_sentiment_score": "0.160313", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.114318", "ticker_sentiment_score": "0.013997", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVX", "relevance_score": "0.076358", "ticker_sentiment_score": "0.237547", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DLTR", "relevance_score": "0.114318", "ticker_sentiment_score": "-0.012573", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.076358", "ticker_sentiment_score": "0.325541", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GRAB", "relevance_score": "0.076358", "ticker_sentiment_score": "0.100305", "ticker_sentiment_label": "Neutral"}, {"ticker": "EADSF", "relevance_score": "0.114318", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRPT", "relevance_score": "0.076358", "ticker_sentiment_score": "-0.159047", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SFTBF", "relevance_score": "0.076358", "ticker_sentiment_score": "0.1052", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.114318", "ticker_sentiment_score": "0.064835", "ticker_sentiment_label": "Neutral"}, {"ticker": "KCGI", "relevance_score": "0.076358", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.114318", "ticker_sentiment_score": "-0.020289", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.076358", "ticker_sentiment_score": "0.060618", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLTR", "relevance_score": "0.076358", "ticker_sentiment_score": "0.114333", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHZF", "relevance_score": "0.038223", "ticker_sentiment_score": "0.063348", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Illumina Stock A Better Pick Over TMO?", "url": "https://www.forbes.com/sites/greatspeculations/2023/05/25/is-illumina-stock-a-better-pick-over-tmo/", "time_published": "20230525T130035", "authors": ["Trefis Team"], "summary": "ILMN trades at a higher valuation of 7.3x trailing revenues, compared to 4.6x for TMO, partly due to its financial position.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/646ef2f45456a7bf7e03a6f8/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.234903, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.754242", "ticker_sentiment_score": "0.375687", "ticker_sentiment_label": "Bullish"}, {"ticker": "TMO", "relevance_score": "0.673971", "ticker_sentiment_score": "0.368379", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why activist investors are going to have a busy year", "url": "https://www.economist.com/business/2023/05/25/why-activist-investors-are-going-to-have-a-busy-year", "time_published": "20230525T125902", "authors": [], "summary": "If you think they have gone soft, think again ...", "banner_image": "https://www.economist.com/img/b/1424/1873/90/media-assets/image/20230527_DE_US.jpg", "source": "The Economist", "category_within_source": "Business", "source_domain": "www.economist.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.040955, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SHAK", "relevance_score": "0.036255", "ticker_sentiment_score": "0.068938", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.072435", "ticker_sentiment_score": "0.056485", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOTMF", "relevance_score": "0.036255", "ticker_sentiment_score": "0.044102", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHZF", "relevance_score": "0.036255", "ticker_sentiment_score": "0.05203", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn's Power Play at Illumina: Potential Board Changes and Management Overhaul - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/05/32570426/carl-icahns-power-play-at-illumina-potential-board-changes-and-management-overhaul", "time_published": "20230525T121913", "authors": ["Vandana Singh"], "summary": "According to undisclosed sources, activist investor Carl Icahn is poised to secure enough shareholder support to place Andrew Teno, an Icahn nominee, to join the board of Illumina Inc ILMN.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/carl_icahn_-_photo_by_insider_monkey_via_flickr_creative_commons.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.139123, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.699089", "ticker_sentiment_score": "0.171962", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Carl Icahn's Battle with Illumina Comes to a Head", "url": "https://www.nytimes.com/2023/05/25/business/icahn-illumina-shareholder-vote.html", "time_published": "20230525T114515", "authors": [], "summary": "Carl Icahn's Proxy Fight With Illumina Comes to a Vote The New York Times ...", "banner_image": "https://static01.nyt.com/images/2023/05/25/multimedia/25db-icahn-bfqc/25db-icahn-bfqc-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": -0.031652, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.020456", "ticker_sentiment_score": "-0.202817", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GOOG", "relevance_score": "0.020456", "ticker_sentiment_score": "0.245102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.020456", "ticker_sentiment_score": "0.099528", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.020456", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.020456", "ticker_sentiment_score": "0.102178", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.081691", "ticker_sentiment_score": "-0.015585", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.102013", "ticker_sentiment_score": "-0.153065", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GS", "relevance_score": "0.020456", "ticker_sentiment_score": "0.102178", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.020456", "ticker_sentiment_score": "0.109413", "ticker_sentiment_label": "Neutral"}]}, {"title": "Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF  ( RYH ) ?", "url": "https://www.zacks.com/stock/news/2099430/should-you-invest-in-the-invesco-sp-500-equal-weight-health-care-etf-ryh", "time_published": "20230525T102006", "authors": ["Zacks Investment Research"], "summary": "Sector ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default84.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.246345, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.130217", "ticker_sentiment_score": "0.070327", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.256989", "ticker_sentiment_score": "0.173379", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.130217", "ticker_sentiment_score": "0.070327", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.130217", "ticker_sentiment_score": "0.070327", "ticker_sentiment_label": "Neutral"}]}, {"title": "Exclusive: Icahn poised to win at least one seat on Illumina's board -sources", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/icahn-poised-win-least-one-seat-illuminas-board-sources-2023-05-25/", "time_published": "20230525T005800", "authors": ["Svea Herbst-Bayliss", "Greg Roumeliotis"], "summary": "Exclusive: Icahn poised to win at least one seat on Illumina's board ... ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/PRTNSJIJEJOAZJ4P4MJ4L3ZK4Y.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.305168, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.672055", "ticker_sentiment_score": "0.378102", "ticker_sentiment_label": "Bullish"}]}, {"title": "Is Invesco S&P 500 Equal Weight Health Care ETF  ( RYH )  a Strong ETF Right Now?", "url": "https://www.zacks.com/stock/news/2098841/is-invesco-sp-500-equal-weight-health-care-etf-ryh-a-strong-etf-right-now", "time_published": "20230524T102006", "authors": ["Zacks Investment Research"], "summary": "Smart Beta ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default26.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999953"}], "overall_sentiment_score": 0.330425, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.118064", "ticker_sentiment_score": "0.067312", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.233556", "ticker_sentiment_score": "0.275816", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.118064", "ticker_sentiment_score": "0.067312", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.118064", "ticker_sentiment_score": "0.067312", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn's wealth has plunged by $15 billion since a short-seller targeted him - but the activist investor says he's ready to fight back", "url": "https://markets.businessinsider.com/news/stocks/carl-icahn-wealth-net-worth-billionaire-investor-short-seller-hindenburg-2023-5", "time_published": "20230523T102300", "authors": ["George Glover"], "summary": "Carl Icahn Fights Back After Hindenburg Report Cuts Wealth by $15 ... - Markets Insider ...", "banner_image": "https://i.insider.com/646c8a22fee1b300197a5aea?width=1200&format=jpeg", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.01684, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.102449", "ticker_sentiment_score": "-0.107024", "ticker_sentiment_label": "Neutral"}]}]}